Valuation: DiaSorin S.p.A.

Market Cap 400.45Cr 447.41Cr 370.3Cr 335.32Cr 626.89Cr 43TCr 637.77Cr 4.45TCr 1.76TCr 22TCr 1.68TCr 1.64TCr 70TCr P/E 2026 *
24.6x
P/E 2027 * 21.1x
Enterprise Value 469.88Cr 524.98Cr 434.5Cr 393.46Cr 735.58Cr 50TCr 748.35Cr 5.23TCr 2.07TCr 26TCr 1.97TCr 1.93TCr 83TCr EV / Sales 2026 *
3.8x
EV / Sales 2027 * 3.46x
Free-Float
37.17%
Yield 2026 *
1.6%
Yield 2027 * 1.67%
1 day+1.48%
1 week+4.74%
Current month+5.34%
1 month+2.66%
3 months+21.22%
6 months+35.28%
Current year+17.90%
1 week 77.02
Extreme 77.02
82.3
1 month 72.8
Extreme 72.8
82.3
Current year 52.34
Extreme 52.34
82.3
1 year 52.34
Extreme 52.34
82.3
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
204.4
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/03/26 Buy

Chief Executive Officer

9,211 0.0165%
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%+4.74%+2.93%-2.27% 441.89Cr
+1.14%-0.01%-17.32%+12.09% 18TCr
-0.33%+3.89%-19.82%+18.17% 12TCr
-0.65%+0.04%+1.20%+32.76% 12TCr
-3.42%+13.34%-44.16%+3.81% 9.33TCr
-0.30%-3.20%-0.81%+74.49% 6.32TCr
+0.04%+1.79%+13.52%+75.53% 5.57TCr
-1.27%+2.42%+5.68%-23.16% 5.42TCr
+1.75%+1.76%-11.02%+38.17% 4.41TCr
+0.03%+5.88%-5.17%-10.31% 3.4TCr
Average -0.34%+3.28%-7.50%+21.93% 7.63TCr
Weighted average by Cap. -0.69%+3.05%-11.88%+22.90%

Financials

2026 *2027 *
Net sales 123.66Cr 138.16Cr 114.35Cr 103.55Cr 193.59Cr 13TCr 196.95Cr 1.38TCr 544.26Cr 6.89TCr 518.57Cr 507.42Cr 22TCr 131.65Cr 147.09Cr 121.74Cr 110.24Cr 206.1Cr 14TCr 209.67Cr 1.46TCr 579.42Cr 7.33TCr 552.08Cr 540.2Cr 23TCr
Net income 18Cr 20Cr 17Cr 15Cr 28Cr 1.93TCr 29Cr 201.68Cr 80Cr 1.01TCr 76Cr 74Cr 3.19TCr 20Cr 23Cr 19Cr 17Cr 32Cr 2.18TCr 33Cr 227.53Cr 90Cr 1.14TCr 86Cr 84Cr 3.6TCr
Net Debt 69Cr 78Cr 64Cr 58Cr 108.69Cr 7.39TCr 110.58Cr 772.25Cr 305.57Cr 3.87TCr 291.15Cr 284.89Cr 12TCr 56Cr 62Cr 51Cr 47Cr 87Cr 5.91TCr 88Cr 617.85Cr 244.48Cr 3.09TCr 232.94Cr 227.93Cr 9.78TCr
Projected Income Statement - Annual - DiaSorin S.p.A.
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
26/26/26 €80.90 +1.48% 95,328
23/26/23 €79.72 +0.10% 1,65,324
22/26/22 €79.64 +1.89% 1,51,184
21/26/21 €78.16 -1.69% 4,61,073
20/26/20 €79.50 +2.74% 1,65,284
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DiaSorin S.p.A.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
80.90EUR
Average target price
76.38EUR
Spread / Average Target
-5.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DiaSorin S.p.A.